Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Montelukast incorporated poly(methyl vinyl ether-co-maleic acid)/poly(lactic-co-glycolic acid) electrospun nanofibers for wound dressing

Montelukast incorporated poly(methyl vinyl ether-co-maleic acid)/poly(lactic-co-glycolic acid)... Abstract The aim of the present study was to prepare nanofibers loaded with montelukast, a cysteinyl leukotrienes (CysLTs) inhibitor, with anti-inflammatory properties effective on wound healing. Polymeric nanofibers containing montelukast were spun by electrospinning method using different ratios of the blend of two biodegradable polymers of poly(methyl vinyl etherco-maleic acid) (PMVEMA) and poly(lactic-co-glycolic acid) (PLGA) at the total polymer concentration of 37 %, the distance of the needle to rotating screen of 19 cm, the voltage of 12 Kv and the rate of injection of 0.2 ml/h. The ratio of two polymers in the blend and the concentration of montelukast were optimized based on the diameter of the nanofibers, drug loading percent and release efficiency by a full factorial design. The morphology, diameter and diameter distribution of the nanofibers were studied by scanning electron microscopy (SEM). Drug loading percent in the nanofibers was determined by extracting the loaded drug from a specific surface of the nanofibers which was subsequently analyzed spectrophotometrically. The drug release rate from the nanofibers was studied in phosphate buffer solution (pH 7.4) containing 0.5 % Tween 20 at predetermined time intervals until 10 days. The cytotoxicity of the designed nanofibers was evaluated on mouse fibroblast cells using trypan blue method, their platelet adherence property was quantified by measuring the lactate dehydrogenase (LDH) activity and confirmed by SEM micrographs. The optimized ratio of PLGA/PMVEMA was 3:1 with the total concentration of polymers as 37 % loaded with 30 % of montelukast produced nanofibers with a diameter of 157.6 nm, drug loading percent of 43.7 % and release efficiency of 75 % after 10 days. The cell viability was similar in nanofibers and the negative control group. The platelets adhesion to the nanofibers was more than the negative control group (p<0.05). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Fibers and Polymers Springer Journals

Montelukast incorporated poly(methyl vinyl ether-co-maleic acid)/poly(lactic-co-glycolic acid) electrospun nanofibers for wound dressing

Fibers and Polymers , Volume 18 (11): 10 – Nov 1, 2017

Loading next page...
 
/lp/springer-journals/montelukast-incorporated-poly-methyl-vinyl-ether-co-maleic-acid-poly-s0uULQpLeL

References (30)

Publisher
Springer Journals
Copyright
2017 The Korean Fiber Society and Springer Science+Business Media B.V., part of Springer Nature
ISSN
1229-9197
eISSN
1875-0052
DOI
10.1007/s12221-017-7438-7
Publisher site
See Article on Publisher Site

Abstract

Abstract The aim of the present study was to prepare nanofibers loaded with montelukast, a cysteinyl leukotrienes (CysLTs) inhibitor, with anti-inflammatory properties effective on wound healing. Polymeric nanofibers containing montelukast were spun by electrospinning method using different ratios of the blend of two biodegradable polymers of poly(methyl vinyl etherco-maleic acid) (PMVEMA) and poly(lactic-co-glycolic acid) (PLGA) at the total polymer concentration of 37 %, the distance of the needle to rotating screen of 19 cm, the voltage of 12 Kv and the rate of injection of 0.2 ml/h. The ratio of two polymers in the blend and the concentration of montelukast were optimized based on the diameter of the nanofibers, drug loading percent and release efficiency by a full factorial design. The morphology, diameter and diameter distribution of the nanofibers were studied by scanning electron microscopy (SEM). Drug loading percent in the nanofibers was determined by extracting the loaded drug from a specific surface of the nanofibers which was subsequently analyzed spectrophotometrically. The drug release rate from the nanofibers was studied in phosphate buffer solution (pH 7.4) containing 0.5 % Tween 20 at predetermined time intervals until 10 days. The cytotoxicity of the designed nanofibers was evaluated on mouse fibroblast cells using trypan blue method, their platelet adherence property was quantified by measuring the lactate dehydrogenase (LDH) activity and confirmed by SEM micrographs. The optimized ratio of PLGA/PMVEMA was 3:1 with the total concentration of polymers as 37 % loaded with 30 % of montelukast produced nanofibers with a diameter of 157.6 nm, drug loading percent of 43.7 % and release efficiency of 75 % after 10 days. The cell viability was similar in nanofibers and the negative control group. The platelets adhesion to the nanofibers was more than the negative control group (p<0.05).

Journal

Fibers and PolymersSpringer Journals

Published: Nov 1, 2017

Keywords: Polymer Sciences

There are no references for this article.